BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Liu ZZ, Huang WY, Lin JS, Li XS, Liang KH, Huang JL. Cell cycle and radiosensitivity of progeny of irradiated primary cultured human hepatocarcinoma cells. World J Gastroenterol 2005; 11(44): 7033-7035 [PMID: 16437612 DOI: 10.3748/wjg.v11.i44.7033]
URL: https://www.wjgnet.com/1007-9327/full/v11/i44/7033.htm
Number Citing Articles
1
Yoshikazu KUWAHARA, Miyuki MORI, Toshiyuki OIKAWA, Tsutomu SHIMURA, Yosuke OHTAKE, Shiro MORI, Yasuhito OHKUBO, Manabu FUKUMOTO. The Modified High-Density Survival Assay is the Useful Tool to Predict the Effectiveness of Fractionated Radiation ExposureJournal of Radiation Research 2010; 51(3): 297 doi: 10.1269/jrr.09094
2
Hae-Na Shin, Shin Hwang, Ki-Hun Kim, Chul-Soo Ahn, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Young-Joo Lee, Sung-Gyu Lee. Role of the 1-month protocol transarterial chemoinfusion in detecting intrahepatic metastasis after resection of large hepatocellular carcinoma greater than 10 cmKorean Journal of Hepato-Biliary-Pancreatic Surgery 2013; 17(4): 157 doi: 10.14701/kjhbps.2013.17.4.157
3
Alan J Wigg, Kevin Palumbo, David R Wigg. Radiotherapy for hepatocellular carcinoma: Systematic review of radiobiology and modeling projections indicate reconsideration of its useJournal of Gastroenterology and Hepatology 2010; 25(4): 664 doi: 10.1111/j.1440-1746.2009.06126.x
4
Luis A. Pérez-Romasanta, Elisabet González-Del Portillo, Ana Rodríguez-Gutiérrez, Ángela Matías-Pérez. Stereotactic Radiotherapy for Hepatocellular Carcinoma, Radiosensitization Strategies and Radiation-Immunotherapy CombinationCancers 2021; 13(2): 192 doi: 10.3390/cancers13020192